Activation of encrypted tissue factor during thrombus formation in vivo

体内血栓形成过程中加密组织因子的激活

基本信息

  • 批准号:
    7532912
  • 负责人:
  • 金额:
    $ 12.66万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-09-22 至 2013-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): As a mechanism of host defense, the initiation of the blood coagulation cascade requires tight regulation both in its timing and location. Major causes of death, including stroke, heart attack and pulmonary embolism, are each linked to pathologic thrombosis. Current teaching of coagulation has evolved from in vitro studies in which isolated components of this complex system are studied individually. My long-term goal is to elucidate the mechanism initiating coagulation in vivo and to determine how this critical step is regulated. Recently developed imaging technologies allow for the study of protein interactions at the site of thrombus formation in a living animal in real time. Tissue factor (TF) is required to initiate blood coagulation, thrombin formation and fibrin generation. It has been dogma that tissue factor is shielded from the circulation and is only exposed by vascular injury. However, TF has been identified on circulating microparticles, as well as on leukocytes and endothelial cells. Recent studies have led to the novel proposal that oxidation of TF leads to disulfide bond formation, acting as a molecular switch that changes latent TF to a procoagulant form. We hypothesize that an encrypted form of TF exists within the circulation that is activated during thrombus formation and fibrin generation in vivo. This would be a novel mechanism of TF involvement in thrombosis. We base this hypothesis on the following observations: 1) in vivo evidence of circulating TF accumulating in a growing thrombus, 2) a discrepancy between circulating TF concentration as measured by antigen and function - circulating antigen far exceeds the amount required to initiate coagulation and 3) disruption of the Cys186-Cys209 disulfide bond in tissue factor decreases its procoagulant activity, and this is reversible by forming this same disulfide bond. Based on these observations, we will characterize active and encrypted tissue factor isoforms in vivo using intravital microscopy and isoform-specific antibodies. We will characterize known antibodies for isoform specificity and have developed novel antibodies using recombinant phage display technology. These antibodies will allow visualization of TF isoforms during laser-induced thrombus formation in a living mouse. Furthermore, mouse models deficient in TF in individual tissues of interest, including monocytes and endothelial cells, will be employed to investigate the role of these tissues in TF-mediated thrombus formation in vivo.
描述(申请人提供):作为一种宿主防御机制,凝血级联的启动在时间和位置上都需要严格的调控。主要的死亡原因,包括中风、心脏病发作和肺栓塞,都与病理性血栓形成有关。目前的凝血教学是从体外研究发展而来的,在体外研究中,这个复杂系统的独立成分被单独研究。我的长期目标是阐明体内启动凝血的机制,并确定这一关键步骤是如何调节的。最近发展起来的成像技术可以实时研究活体动物血栓形成部位的蛋白质相互作用。组织因子(TF)是启动凝血、凝血酶形成和纤维蛋白生成所必需的。人们一直认为,组织因子被屏蔽在循环之外,只有在血管损伤时才会暴露。然而,已经在循环微粒以及白细胞和内皮细胞上发现了转铁蛋白。最近的研究导致了一种新的观点,即Tf的氧化导致二硫键的形成,作为分子开关将潜在的Tf转变为促凝剂形式。我们假设在体内血栓形成和纤维蛋白生成过程中激活的循环中存在一种加密形式的转铁蛋白。这可能是TF参与血栓形成的一种新机制。我们基于以下观察结果提出这一假说:1)体内有证据表明循环中的TF积聚在不断生长的血栓中,2)抗原测量的循环中的TF浓度与功能循环抗原之间的差异远远超过启动凝血所需的量,3)组织因子中的Cys186-Cys209二硫键的破坏降低了其促凝血活性,这是通过形成相同的二硫键而可逆的。在这些观察的基础上,我们将使用活体显微镜和异构体特异性抗体来表征体内活跃的和加密的组织因子亚型。我们将鉴定已知抗体的异构体特异性,并利用重组噬菌体展示技术开发新的抗体。这些抗体将使激光诱导的活体小鼠血栓形成过程中的转铁蛋白亚型可视化。此外,将利用单个感兴趣的组织(包括单核细胞和内皮细胞)中缺乏转铁蛋白的小鼠模型来研究这些组织在体内转铁蛋白介导的血栓形成中的作用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Cameron Trenor其他文献

Cameron Trenor的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Cameron Trenor', 18)}}的其他基金

Activation of encrypted tissue factor during thrombus formation in vivo
体内血栓形成过程中加密组织因子的激活
  • 批准号:
    8268395
  • 财政年份:
    2008
  • 资助金额:
    $ 12.66万
  • 项目类别:
Activation of encrypted tissue factor during thrombus formation in vivo
体内血栓形成过程中加密组织因子的激活
  • 批准号:
    8070020
  • 财政年份:
    2008
  • 资助金额:
    $ 12.66万
  • 项目类别:
Activation of encrypted tissue factor during thrombus formation in vivo
体内血栓形成过程中加密组织因子的激活
  • 批准号:
    7689915
  • 财政年份:
    2008
  • 资助金额:
    $ 12.66万
  • 项目类别:
Activation of encrypted tissue factor during thrombus formation in vivo
体内血栓形成过程中加密组织因子的激活
  • 批准号:
    7849590
  • 财政年份:
    2008
  • 资助金额:
    $ 12.66万
  • 项目类别:

相似海外基金

Rationally guided discovery platform for monoclonal antibodies against carbohydrate antigens using virus-like particle conjugate immunization and high throughput selection
使用病毒样颗粒缀合物免疫和高通量选择的合理引导的针对碳水化合物抗原的单克隆抗体的发现平台
  • 批准号:
    10574738
  • 财政年份:
    2023
  • 资助金额:
    $ 12.66万
  • 项目类别:
Assessing the role of liver stage antigens-specific antibodies against Plasmodium falciparum liver stage infection
评估肝期抗原特异性抗体对抗恶性疟原虫肝期感染的作用
  • 批准号:
    10392870
  • 财政年份:
    2021
  • 资助金额:
    $ 12.66万
  • 项目类别:
Generation of antibodies specific for optimal non-HRP2 malaria diagnostic antigens
生成最佳非 HRP2 疟疾诊断抗原的特异性抗体
  • 批准号:
    10092930
  • 财政年份:
    2020
  • 资助金额:
    $ 12.66万
  • 项目类别:
Generation of antibodies specific for optimal non-HRP2 malaria diagnostic antigens
生成最佳非 HRP2 疟疾诊断抗原的特异性抗体
  • 批准号:
    9896170
  • 财政年份:
    2020
  • 资助金额:
    $ 12.66万
  • 项目类别:
Interrogation of cell surface antigens on B lineage cells using structurally unique variable lymphocyte receptor antibodies of the evolutionarily distant sea lamprey
使用进化遥远的海七鳃鳗结构独特的可变淋巴细胞受体抗体询问 B 谱系细胞上的细胞表面抗原
  • 批准号:
    433456
  • 财政年份:
    2020
  • 资助金额:
    $ 12.66万
  • 项目类别:
    Operating Grants
Investigations of interactions between various natural antibodies and food-derived antigens
研究各种天然抗体与食物源性抗原之间的相互作用
  • 批准号:
    19K15765
  • 财政年份:
    2019
  • 资助金额:
    $ 12.66万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Identifying Kawasaki Disease-Specific Antibodies and Antigens
识别川崎病特异性抗体和抗原
  • 批准号:
    9932769
  • 财政年份:
    2018
  • 资助金额:
    $ 12.66万
  • 项目类别:
Novel Scoring Methods for Interactions between Antibodies and Antigens
抗体和抗原之间相互作用的新评分方法
  • 批准号:
    BB/P504713/1
  • 财政年份:
    2017
  • 资助金额:
    $ 12.66万
  • 项目类别:
    Training Grant
Novel Scoring Methods for Interactions between Antibodies and Antigens
抗体和抗原之间相互作用的新评分方法
  • 批准号:
    1932904
  • 财政年份:
    2017
  • 资助金额:
    $ 12.66万
  • 项目类别:
    Studentship
SBIR Phase II: Automated Design Methods of Antibodies Directed to Protein and Carbohydrate Antigens
SBIR II 期:针对蛋白质和碳水化合物抗原的抗体的自动化设计方法
  • 批准号:
    1632399
  • 财政年份:
    2016
  • 资助金额:
    $ 12.66万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了